1. Home
  2. PDM vs GERN Comparison

PDM vs GERN Comparison

Compare PDM & GERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDM
  • GERN
  • Stock Information
  • Founded
  • PDM 1997
  • GERN 1990
  • Country
  • PDM United States
  • GERN United States
  • Employees
  • PDM N/A
  • GERN N/A
  • Industry
  • PDM Building operators
  • GERN Biotechnology: Pharmaceutical Preparations
  • Sector
  • PDM Real Estate
  • GERN Health Care
  • Exchange
  • PDM Nasdaq
  • GERN Nasdaq
  • Market Cap
  • PDM 860.9M
  • GERN 853.5M
  • IPO Year
  • PDM N/A
  • GERN 1996
  • Fundamental
  • Price
  • PDM $7.41
  • GERN $1.51
  • Analyst Decision
  • PDM Buy
  • GERN Buy
  • Analyst Count
  • PDM 5
  • GERN 7
  • Target Price
  • PDM $9.40
  • GERN $4.17
  • AVG Volume (30 Days)
  • PDM 1.1M
  • GERN 10.9M
  • Earning Date
  • PDM 07-30-2025
  • GERN 08-07-2025
  • Dividend Yield
  • PDM 6.76%
  • GERN N/A
  • EPS Growth
  • PDM N/A
  • GERN N/A
  • EPS
  • PDM N/A
  • GERN N/A
  • Revenue
  • PDM $568,472,000.00
  • GERN $116,293,000.00
  • Revenue This Year
  • PDM $0.50
  • GERN $160.12
  • Revenue Next Year
  • PDM N/A
  • GERN $55.01
  • P/E Ratio
  • PDM N/A
  • GERN N/A
  • Revenue Growth
  • PDM N/A
  • GERN 22264.04
  • 52 Week Low
  • PDM $5.46
  • GERN $1.17
  • 52 Week High
  • PDM $11.12
  • GERN $5.06
  • Technical
  • Relative Strength Index (RSI)
  • PDM 55.38
  • GERN 51.36
  • Support Level
  • PDM $7.34
  • GERN $1.42
  • Resistance Level
  • PDM $7.82
  • GERN $1.58
  • Average True Range (ATR)
  • PDM 0.21
  • GERN 0.10
  • MACD
  • PDM -0.02
  • GERN -0.01
  • Stochastic Oscillator
  • PDM 46.79
  • GERN 40.00

About PDM Piedmont Office Realty Trust Inc.

Piedmont Office Realty Trust Inc is a real estate investment trust engaged in the acquisition, development, and management of commercial real estate properties throughout the U.S. The company's real estate portfolio is mainly composed of office properties located in the majority of American metropolitan areas. Piedmont derives the majority of its revenue in the form of rental income from tenants in mid- to long-term lease agreements. The vast majority of the company's revenue comes from the leasing of its assets in Washington D.C., New York City, Chicago, Atlanta, Minneapolis, Dallas, and Boston. Piedmont's large customers in terms of rental revenue are U.S. Government entities, business services companies, and financial institutions.

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

Share on Social Networks: